Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension

[1]  David A Bluemke,et al.  Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling. , 2011, AJR. American journal of roentgenology.

[2]  Christopher S Coffey,et al.  Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) , 2010, Circulation.

[3]  M. Sheppard,et al.  Understanding late gadolinium enhancement in pulmonary hypertension. , 2010, Circulation. Cardiovascular imaging.

[4]  R. Mohiaddin,et al.  Measuring the heart in pulmonary arterial hypertension (PAH): Implications for trial study size , 2010, Journal of magnetic resonance imaging : JMRI.

[5]  P. Hassoun,et al.  Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. , 2009, Circulation.

[6]  Sanjiv J. Shah,et al.  Value of Exercise Treadmill Testing in the Risk Stratification of Patients With Pulmonary Hypertension , 2009, Circulation. Heart failure.

[7]  E. Gasparetto,et al.  Myocardial delayed enhancement in patients with pulmonary hypertension and right ventricular failure: evaluation by cardiac MRI. , 2009, The British journal of radiology.

[8]  Himanshu Gupta,et al.  Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension. , 2008, Journal of the American College of Cardiology.

[9]  V. Fuster,et al.  Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. , 2007, The American journal of cardiology.

[10]  D. Huo,et al.  Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  J. Bronzwaer,et al.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. , 2007, European heart journal.

[12]  H. Niessen,et al.  Extent of MRI delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension. , 2007, AJR. American journal of roentgenology.

[13]  D. Badesch,et al.  Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. , 2007, Chest.

[14]  D. Badesch,et al.  Evidence-Based Clinical Practice Guidelines Hypertension: Updated ACCP Medical Therapy for Pulmonary Arterial , 2007 .

[15]  D. Pennell,et al.  Journal of Cardiovascular Magnetic Resonance Open Access Feasibility and Initial Experience of Assessment of Mechanical Dyssynchrony Using Cardiovascular Magnetic Resonance and Semi-automatic Border Detection , 2008 .

[16]  N. Zafrir,et al.  Use of noninvasive tools in primary pulmonary hypertension to assess the correlation of right ventricular function with functional capacity and to predict outcome , 2007, The International Journal of Cardiovascular Imaging.

[17]  C. Ricachinevsky,et al.  Treatment of pulmonary arterial hypertension. , 2006, Jornal de pediatria.

[18]  J. Foster,et al.  Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. , 2005, European heart journal.

[19]  Morton F Arnsdorf,et al.  The prognostic value of a nomogram for exercise capacity in women. , 2005, The New England journal of medicine.

[20]  R. Barst,et al.  New predictors of outcome in idiopathic pulmonary arterial hypertension. , 2005, The American journal of cardiology.

[21]  D. Mccrory,et al.  Medical Therapy For Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines , 2004 .

[22]  Dudley J Pennell,et al.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[23]  R. Speich,et al.  Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.

[24]  J. Sandoval,et al.  Right ventricular ischemia in patients with primary pulmonary hypertension. , 2001, Journal of the American College of Cardiology.

[25]  V L Morgan,et al.  Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. , 1999, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[26]  V. Froelicher,et al.  Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men. , 1993, Journal of the American College of Cardiology.

[27]  E H Bergofsky,et al.  Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .

[28]  J. Naughton,et al.  Treadmill exercise in assessment of the functional capacity of patients with cardiac disease. , 1972, The American journal of cardiology.